Login
NEXTGEN HEALTHCARE, INC. logo

NEXTGEN HEALTHCARE, INC.

nextgen.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q2 FY2024 10-Q, filed Oct 24, 2023. Its latest SEC filing is a 15-12G from Nov 20, 2023.

The sections below describe the company as of the FY2023 annual report.

What Did They Do?

Provides cloud-based electronic health records, practice management, and related health technology for ambulatory medical, behavioral, and oral health providers.

How Did They Make Money?

Ambulatory care organizations pay for software licenses, subscriptions, support and maintenance, managed services, data and transaction services, and implementation and consulting. Subscriptions and service contracts are generally billed over their term, while implementation and other one-time services are billed for completed work.

revenue
SegmentShareRevenue
Recurring
Mix

91%
FY2020: 91%
Software, Hardware, and Other Non-recurring
Mix

9.1%
FY2020: 9.4%

Who Were Their Customers?

Ambulatory practices, from large multispecialty groups to sole practitioners, and networks such as community health centers buy the solutions. Sales are primarily direct, with a smaller reseller channel.

Did Revenues Turn Into Profits?

Not on paper. It lost $2.7M in FY2023, but brought in more cash than it spent: $41.4M of free cash flow.

Operating income, FY2023
−1% of revenue
▼ Now a loss vs FY2022 ($6.7M, 1%)
Net income, FY2023
0% of revenue
▼ Now a loss vs FY2022 ($1.6M, 0%)
Free cash flow, FY2023
6% of revenue
▼ −19% vs FY2022 ($51M, 9%)

How Were They Changing?

Since the FY2023 annual report
Latest quarter: Q2 FY2024, the three months to Sep 30, 2023
Revenue
▲ +11%
vs $159.4M in Q2 FY2023
Net income
▼ −63%
vs $13.6M in Q2 FY2023
Recurring share of revenue vs 90.0% in Q2 FY2023
  • Nov 9, 2023 Thoma Bravo completed its acquisition of NextGen Healthcare NextGen became a wholly owned subsidiary of Parent, and shareholders received $23.95 per share in cash.
  • Sep 6, 2023 NextGen agreed to be acquired by Thoma Bravo The agreement provided for shareholders to receive $23.95 per share in cash, subject to closing conditions.

Grew. Revenue grew 23% in 4 years, from $529.2M in FY2019 to $653.2M in FY2023, about 5% a year.

Revenue over time
Recurring Software, Hardware, and Other Non-recurring
$1B$500M$0

Who Did They Compete With?

Competes with athenahealth, Oracle, eClinicalWorks, Epic Systems, Greenway Health, Veradigm, and Modernizing Medicine

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support